SEC Form 4 · accession 0001209191-17-040176
SPECTRUM PHARMACEUTICALS INC · SPPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony E Maida III
Director
Period of report
Jun 13, 2017
Accepted (ET)
Jun 15, 2017 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Jun 13, 2017 | F | 3,523 | $6.48 | D | 13,055 | D | |
| Common Stock, $0.001 par valueF2 | Jun 13, 2017 | A | 10,000 | $0.00 | A | 23,055 | D | |
| Common Stock, $0.001 par value | holding | — | — | — | 8,517 | I | By Daughter |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $6.48 | Jun 13, 2017 | A | 20,000 | A | — | Jun 13, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Represents shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent.
- F2100% of the restricted shares shall vest on the earlier of (1) June 13, 2018 or (2) the date of the company's 2018 Annual Meeting of Shareholders.
- F325% of the option shares vested on June 13, 2017. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.